The goal of this study is to evaluate whether hormonal medications (such as contraceptive pill, patch, injectable progestins and hormonal intra-uterine device) have similar efficacy at managing heavy menstrual bleeding in adolescents with a bleeding disorder compared to those without. We also aim to assess the quality of life and hemoglobin and iron levels in this population.
Eligibility
Sex
FEMALE
Min age
—
Max age
25 Years
Healthy volunteers
No
Inclusion Criteria:
* Adolescents and young adults aged \< 26yo
* Presenting to the gynecology consultation at HUG
* Diagnosed with heavy menstrual bleeding (PBAC \> 100)
* Willing to initiate a hormonal medication to manage heavy menstrual bleeding
Exclusion Criteria:
* Pregnancy or planning to become pregnant during the study period
* Already using hormonal medication for menstrual management and/or contraception
* Known anatomical uterine pathology
* Using anticoagulant or antiaggregant agents
Primary outcome measure(s)
Percentage of reduction in menstrual blood loss — 6 months after hormonal medication initiation Using PBAC (pictorial blood loss assessment chart)
Trial sites (1)
Facility
City
Region
Status
Geneva University Hospitals
Geneva
Switzerland
Recruiting
More University Hospital, Geneva trials in Switzerland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
